(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells (Q39707051)

14 September 2017

(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells (English)

1 reference

14 September 2017

1 reference

Alessio Papi

2

0 references

author name string

Fulvia Farabegoli

series ordinal

1

1 reference

PubMed ID

20446926

14 September 2017

Marina Orlandi

series ordinal

3

1 reference

14 September 2017

1 April 2011

1 reference

14 September 2017

1 reference

14 September 2017

31

1 reference

14 September 2017

99-108

1 reference

14 September 2017

2

1 reference

Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy

14 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Pathways to tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Modulation of signal transduction by tea catechins and related phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Structure and function of matrix metalloproteinases and TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

The combination of green tea and tamoxifen is effective against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20090143

21 January 2018

Identifiers

DOI

10.1042/BSR20090143

1 reference

14 September 2017

1 reference

PubMed ID

20446926